Explore our materials

Filters

Results (4227)

Daniel Kuritzkes

Video

RSV

Monkeypox Clinical Forum 2022

Monkeypox Treatment and Prevention - Daniel Kuritzkes

Dimie Ogoina

MBBS, FWACP, FMCP-Infectious Diseases, FACP, FIDSA

Video

RSV

Monkeypox Clinical Forum 2022

Comparing the Epidemiology and Clinical Presentation of Monkeypox in Nigeria and the Global North - Dimie Ogoina

Chloe Orkin

MBChB, FRCP, MD

Video

RSV

Monkeypox Clinical Forum 2022

Case Recognition and Case Definition in the Multi-Country Outbreak - Chloe Orkin

Paolo Lusso

MD, PhD

Leveraging mRNA Technology Workshop - 1st Edition

Paolo Lusso | mRNA Vaccines for HIV

Matthew Gagne

PhD

Leveraging mRNA Technology Workshop - 1st Edition

Matthew Gagne | Scientific Update on mRNA Vaccines for COVID-19 and Implications for Boosting Strategy

JRS

John R. Su

MD, PhD, MPH

Leveraging mRNA Technology Workshop - 1st Edition

John R. Su | Safety Profiles of COVID-19 Vaccines

Tracy Ruckwardt

PhD

Leveraging mRNA Technology Workshop - 1st Edition

Tracy Ruckwardt | Vaccines for Respiratory Syncytial Virus

Norbert Pardi

PhD

Leveraging mRNA Technology Workshop - 1st Edition

Norbert Pardi | Development of Universal Influenza Vaccines Using Nucleoside-Modified mRNA

M. Anthony Moody

Leveraging mRNA Technology Workshop - 1st Edition

M. Anthony Moody | Clinical Update on mRNA Vaccines for Flu

Elie Dolgin

PhD

Leveraging mRNA Technology Workshop - 1st Edition

Elie Dolgin | Opening Lecture on mRNA Technology: Historical Perspective

James Brien

PhD

Leveraging mRNA Technology Workshop - 1st Edition

James Brien | Polyvalent Vaccines

Karine Breckpot

PhD

Leveraging mRNA Technology Workshop - 1st Edition

Explore our materials

Your Selection Clear All

Topic

Material Type

Monkeypox Treatment and Prevention - Daniel Kuritzkes

Comparing the Epidemiology and Clinical Presentation of Monkeypox in Nigeria and the Global North - Dimie Ogoina

Case Recognition and Case Definition in the Multi-Country Outbreak - Chloe Orkin

Paolo Lusso | mRNA Vaccines for HIV

Matthew Gagne | Scientific Update on mRNA Vaccines for COVID-19 and Implications for Boosting Strategy

John R. Su | Safety Profiles of COVID-19 Vaccines

Tracy Ruckwardt | Vaccines for Respiratory Syncytial Virus

Norbert Pardi | Development of Universal Influenza Vaccines Using Nucleoside-Modified mRNA

M. Anthony Moody | Clinical Update on mRNA Vaccines for Flu

Elie Dolgin | Opening Lecture on mRNA Technology: Historical Perspective

James Brien | Polyvalent Vaccines

Karine Breckpot | RNA Vaccine Platforms: Activation of Neoantigen Specific T cells for the Treatment of Solid Tumors